Joint diseases are one of the most common causes of morbidity and disability worldwide.
The main diseases that affect joint cartilage are osteoarthritis and rheumatoid arthritis, which …

With the success of several clinical trials of products based on human serum albumin (HSA)
and the rapid development of nanotechnology, HSA-based nanodrug delivery systems …

Macrophages play essential roles in the progression of rheumatoid arthritis (RA), which are
polarized into the pro‐inflammatory M1 phenotype with significant oxidative stress and …

Progress has been made in the application of nanomedicine in rheumatoid arthritis (RA)
treatment. However, the whole process of monitoring and treatment of RA remains a …

Reactive oxygen species (ROS)‐mediated biological catalysis involves serial programmed
enzymatic reactions and plays an important part against infectious diseases; while the …

Rheumatoid arthritis (RA) is a debilitating autoimmune disease that causes chronic pain and
serious complications, presenting a significant challenge to treat. Promising approaches for …

Rational design of metallic active sites and its microenvironment is critical for constructing
superoxide dismutase (SOD) nanozymes. Here, we reported a novel SOD nanozyme …

Inflammation-related diseases affect large populations of people in the world and cause
substantial healthcare burdens, which results in significant costs in time, material, and labor …

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease, which is characterized
by synovial inflammation and autoimmunity. The main cause of the disease is the imbalance …

Background Attenuating inflammatory response and relieving pain are two therapeutic
therapeutical goals for rheumatoid arthritis (RA). Anti-inflammatory and analgesic drugs are …